ArborGen Holdings (ARB) AGM 2024 summary

Opening remarks and agenda

• Chairman confirmed quorum, welcomed shareholders, introduced board members, auditors, and advisors, and explained online participation and voting procedures.

• Annual Shareholders' Meeting held on 26 August 2024.

Financial performance review

• Achieved record revenue of $67.7 million (up 21%) and record adjusted U.S. GAAP EBITDA of $12.8 million (up 39%).

• Gross profit increased 32% to $24.0 million; net loss after tax improved from $2.5 million to $0.2 million.

• Borrowings reduced to $20 million, with gearing down from 23% to 13% over four years.

• Brazil delivered record revenue of $26.5 million, up 58% year-on-year, with strong pricing, volume, and margin growth.

• US South revenue remained strong at $41.2 million despite subdued volumes, focusing on higher margin products.

Board and executive committee updates

• CEO transition from Andrew Baum to Justin Birch was highlighted as a major success; Justin Birch is the current CEO.

• David Knott serves as Chair but is not classified as independent due to substantial shareholding.

• Board includes independent directors George Adams, Paul Smart, Thomas Avery, and Ozey Horton; directors Dave Knott, Tom Avery, and Ozey Horton stood for re-election.

• Remuneration Committee clarified CEO share allocation: half awarded for tenure, half withheld as budget was narrowly missed.